BAYLEI SLACK: Open Payments
NPI 1417436882 · HUTCHINSON, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 20 payments from 9 companies in 2025. Trend: 2023 $154 · 2024 $120 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $93 |
| Lilly USA, LLC | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| PFIZER INC. | 2 | $30 |
| GENZYME CORPORATION | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: VRAYLAR, MOUNJARO, JARDIANCE, GEMTESA, NURTEC ODT, AIRSUPRA, DUPIXENT, Auvelity.
Industry payments across KS — which companies pay providers there.
